FDA inspection
Huiling Pharmaceutical (China) Co., Ltd: FDA inspection ending Aug 22, 2025
FDA inspection 1281212 · Voluntary Action Indicated (VAI) · Zhongshan
Key facts
| Inspection ID | 1281212 |
|---|---|
| Firm | Huiling Pharmaceutical (China) Co., Ltd |
| FEI number | 3009226362 |
| Address | No. 6 Huiling Road, National Health Technology Industrial Base Park |
| City | Zhongshan |
| Fiscal year | 2025 |
| Inspection end date | Aug 22, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data